This company is no longer activeThe company may no longer be operating, as it may be out of business. Find out why through their latest events.See Latest EventsHPX (HPX) 주식 개요HPX Corp. does not have significant operations. 자세히 보기HPX 펀더멘털 분석스노우플레이크 점수가치 평가1/6미래 성장0/6과거 실적1/6재무 건전성0/6배당0/6위험 분석수익이 USD$1m 미만입니다($0)마이너스 주주 지분부채는 operating cash flow로 충분히 감당되지 않습니다.지난 3개월 동안 주가 변동성이 US 시장과 비교했을 때 매우 높았습니다.모든 위험 점검 보기HPX Community Fair Values Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.Your Fair ValueUS$Current PriceUS$17.25해당 없음내재 할인율Est. Revenue$PastFuture04m2016201920222025202620282031Revenue US$1.0Earnings US$0AdvancedSet Fair ValueView all narrativesHPX Corp. 경쟁사Northern Star Investment IVSymbol: OTCPK:NSTDMarket cap: US$3.7kM3-Brigade Acquisition IISymbol: NYSE:MBACMarket cap: US$153.9mLeo Holdings IISymbol: NYSE:LHCMarket cap: US$165.6mPyrophyte AcquisitionSymbol: OTCPK:PHYT.FMarket cap: US$82.2m가격 이력 및 성과HPX 주가의 최고가, 최저가 및 변동 요약과거 주가현재 주가US$17.2552주 최고가US$50.5052주 최저가US$9.59베타0.000341개월 변동73.02%3개월 변동74.24%1년 변동74.24%3년 변동n/a5년 변동n/aIPO 이후 변동72.33%최근 뉴스 및 업데이트Valuation Update With 7 Day Price Move • Mar 02Investor sentiment improves as stock rises 170%After last week's 170% share price gain to US$27.07, the stock trades at a trailing P/E ratio of 67.6x. Average trailing P/E is 28x in the Capital Markets industry in the US. Total returns to shareholders of 173% over the past year.Board Change • Feb 14High number of new and inexperienced directorsThere are 7 new directors who have joined the board in the last 3 years. The company's board is composed of: 7 new directors. No experienced directors. No highly experienced directors. CEO, CFO & Director Carlos Leone Piani is the most experienced director on the board, commencing their role in 2020. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of board continuity. Lack of experienced directors.공시 • Nov 15HPX Corp. announced delayed 10-Q filingOn 11/14/2022, HPX Corp. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.공시 • Jul 093GA Participações S.A. entered into a business combination agreement to acquire HPX Corp. (NYSE:HPX) from HPX Capital Partners LLC and others in a reverse merger transaction.3GA Participações S.A. entered into a business combination agreement to acquire HPX Corp. (NYSE:HPX) from HPX Capital Partners LLC and others in a reverse merger transaction on July 5, 2022. The combined company is expected to have a pro-forma enterprise value of approximately $581 million and a pro-forma implied market capitalization of approximately $798 million, assuming no redemptions from HPX Corp. shareholders. Upon closing of the Business Combination, Ambipar Emergency Response (“Ambipar Response”), a newly incorporated Cayman Islands exempted company that will hold the business of Emergência Participações S.A., is expected to become publicly listed on the NYSE under the ticker symbol “AMBI.” Ambipar Participações e Empreendimentos S.A. (“Ambipar Group”) (B3: AMBP3), currently the sole shareholder of Emergência Participações S.A., will remain a majority shareholder of Ambipar Response with an approximate 50% equity stake in Ambipar Response following the closing of the Business Combination and assuming no redemptions from HPX’s existing public shareholders, and up to 72% in case of total redemptions of HPX existing public shareholders. The economic ownership structure following the Business Combination is expected to be approximately: 50% Ambipar Group, 48% PIPE and HPX public shareholders, and 2% HPX sponsor. The consummation of the transactions contemplated by the Business Combination Agreement is subject to customary closing conditions, including approval by shareholders of HPX and Ambipar; HPX having at least $5,000,001 of net tangible assets; the receipt of approval for the New PubCo Class A Ordinary Shares to be listed on NYSE; delivery of the Contribution Agreement; HPX shall have at least $168,000,000 in cash and cash equivalents in the Trust Account; Parties will have received or have been deemed to have received all other necessary pre-Closing authorizations, consents, clearances, waivers and approvals of the Governmental Entities; The Registration Statement shall have become effective in accordance with the provisions of the Securities Act and other conditions. The Business Combination has been unanimously approved by the Board of Directors of Ambipar Group and HPX. Ambipar Participações e Empreendimentos S.A., shareholder of Emergência Participações S.A. also approved the merger agreement. Transaction is expected to close during the second half of 2022. Bank of America Merrill Lynch Banco Múltiplo S.A. is serving as financial advisor to Ambipar Response and Ambipar Group, and BofA Securities, Inc. is serving as the placement agent in connection with the PIPE offering. Mark Pflug and Grenfel Calheiros, Mark Brod, Tristan Brown, Lori Lesser, Mick Tuesley of Simpson Thacher & Bartlett LLP serving as U.S. legal advisors to Ambipar Response and Ambipar Group, and Mattos Filho, Veiga Filho, Marrey Jr e Quiroga Advogados is serving as Brazilian legal advisor to Ambipar Response and Ambipar Group. J. Mathias von Bernuth and Maxim Mayer-Cesiano of Skadden, Arps, Slate, Meagher & Flom LLP serving as U.S. legal advisors to HPX, Greenberg Traurig, LLP is serving as legal advisor on certain international diligence matters for HPX and BRZ Advogados as legal advisor on Brazilian matters. Shearman & Sterling LLP is acting as legal advisor to BofA Securities, Inc. in its capacity as the placement agent.공시 • May 17HPX Corp. announced delayed 10-Q filingOn 05/16/2022, HPX Corp. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.공시 • Apr 01HPX Corp. announced delayed annual 10-K filingOn 03/31/2022, HPX Corp. announced that they will be unable to file their next 10-K by the deadline required by the SEC.더 많은 업데이트 보기Recent updatesValuation Update With 7 Day Price Move • Mar 02Investor sentiment improves as stock rises 170%After last week's 170% share price gain to US$27.07, the stock trades at a trailing P/E ratio of 67.6x. Average trailing P/E is 28x in the Capital Markets industry in the US. Total returns to shareholders of 173% over the past year.Board Change • Feb 14High number of new and inexperienced directorsThere are 7 new directors who have joined the board in the last 3 years. The company's board is composed of: 7 new directors. No experienced directors. No highly experienced directors. CEO, CFO & Director Carlos Leone Piani is the most experienced director on the board, commencing their role in 2020. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of board continuity. Lack of experienced directors.공시 • Nov 15HPX Corp. announced delayed 10-Q filingOn 11/14/2022, HPX Corp. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.공시 • Jul 093GA Participações S.A. entered into a business combination agreement to acquire HPX Corp. (NYSE:HPX) from HPX Capital Partners LLC and others in a reverse merger transaction.3GA Participações S.A. entered into a business combination agreement to acquire HPX Corp. (NYSE:HPX) from HPX Capital Partners LLC and others in a reverse merger transaction on July 5, 2022. The combined company is expected to have a pro-forma enterprise value of approximately $581 million and a pro-forma implied market capitalization of approximately $798 million, assuming no redemptions from HPX Corp. shareholders. Upon closing of the Business Combination, Ambipar Emergency Response (“Ambipar Response”), a newly incorporated Cayman Islands exempted company that will hold the business of Emergência Participações S.A., is expected to become publicly listed on the NYSE under the ticker symbol “AMBI.” Ambipar Participações e Empreendimentos S.A. (“Ambipar Group”) (B3: AMBP3), currently the sole shareholder of Emergência Participações S.A., will remain a majority shareholder of Ambipar Response with an approximate 50% equity stake in Ambipar Response following the closing of the Business Combination and assuming no redemptions from HPX’s existing public shareholders, and up to 72% in case of total redemptions of HPX existing public shareholders. The economic ownership structure following the Business Combination is expected to be approximately: 50% Ambipar Group, 48% PIPE and HPX public shareholders, and 2% HPX sponsor. The consummation of the transactions contemplated by the Business Combination Agreement is subject to customary closing conditions, including approval by shareholders of HPX and Ambipar; HPX having at least $5,000,001 of net tangible assets; the receipt of approval for the New PubCo Class A Ordinary Shares to be listed on NYSE; delivery of the Contribution Agreement; HPX shall have at least $168,000,000 in cash and cash equivalents in the Trust Account; Parties will have received or have been deemed to have received all other necessary pre-Closing authorizations, consents, clearances, waivers and approvals of the Governmental Entities; The Registration Statement shall have become effective in accordance with the provisions of the Securities Act and other conditions. The Business Combination has been unanimously approved by the Board of Directors of Ambipar Group and HPX. Ambipar Participações e Empreendimentos S.A., shareholder of Emergência Participações S.A. also approved the merger agreement. Transaction is expected to close during the second half of 2022. Bank of America Merrill Lynch Banco Múltiplo S.A. is serving as financial advisor to Ambipar Response and Ambipar Group, and BofA Securities, Inc. is serving as the placement agent in connection with the PIPE offering. Mark Pflug and Grenfel Calheiros, Mark Brod, Tristan Brown, Lori Lesser, Mick Tuesley of Simpson Thacher & Bartlett LLP serving as U.S. legal advisors to Ambipar Response and Ambipar Group, and Mattos Filho, Veiga Filho, Marrey Jr e Quiroga Advogados is serving as Brazilian legal advisor to Ambipar Response and Ambipar Group. J. Mathias von Bernuth and Maxim Mayer-Cesiano of Skadden, Arps, Slate, Meagher & Flom LLP serving as U.S. legal advisors to HPX, Greenberg Traurig, LLP is serving as legal advisor on certain international diligence matters for HPX and BRZ Advogados as legal advisor on Brazilian matters. Shearman & Sterling LLP is acting as legal advisor to BofA Securities, Inc. in its capacity as the placement agent.공시 • May 17HPX Corp. announced delayed 10-Q filingOn 05/16/2022, HPX Corp. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.공시 • Apr 01HPX Corp. announced delayed annual 10-K filingOn 03/31/2022, HPX Corp. announced that they will be unable to file their next 10-K by the deadline required by the SEC.공시 • May 29HPX Corp. Receives Notice from the NYSE Regarding Delayed Filing of Quarterly ReportOn April 12, 2021, the Acting Director of the Division of Corporation Finance and Acting Chief Accountant of the U.S. Securities and Exchange Commission (the “SEC”) together issued a statement regarding the accounting and reporting considerations for warrants issued by special purpose acquisition companies entitled “Staff Statement on Accounting and Reporting Considerations for Warrants Issued by Special Purpose Acquisition Companies (‘SPACs’)” (the “SEC Staff Statement”). As previously disclosed, given the scope of the process for determining the appropriate accounting treatment of its outstanding warrants in accordance with the SEC Staff Statement and Accounting Standards Codification (“ASC”) 815-40, Derivatives and Hedging: Contracts in an Entities Own Equity, HPX Corp. (the “Company”) was unable to complete and file its Quarterly Report on Form 10-Q for the fiscal quarter ended March 31, 2021 (the “Form 10-Q”) by the required due date without unreasonable effort and expense. On May 25, 2021, HPX Corp. received a notice (the “Notice”) from the New York Stock Exchange (the “Exchange”) indicating that, as a result of not having timely filed the Form 10-Q with the SEC, the Company is not in compliance with Section 802.01E of the NYSE Listed Company Manual (the “Listing Rule”). The Listing Rule requires listed companies to timely file all required periodic reports with the SEC. The Notice indicated that the Company can regain compliance with the Exchange’s listing standards at any time prior to November 24, 2021 by filing the Form 10-Q. If the Company fails to file the Form 10-Q by such date, the Exchange may grant, at its sole discretion, an extension for the Company to regain compliance, depending on the specific circumstances. The Notice also stated that the Exchange may nevertheless commence delisting proceedings at any time if it deems that the circumstances warrant. While the Company can provide no assurances as to timing, the Company plans to file the Form 10-Q as soon as practicably possible, and no later than November 24, 2021, and regaining compliance with the Listing Rule.공시 • May 19HPX Corp. announced delayed 10-Q filingOn 05/18/2021, HPX Corp. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.Is New 90 Day High Low • Jan 26New 90-day high: US$10.61The company is up 10.0% from its price of US$9.65 on 27 October 2020. The American market is up 17% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Capital Markets industry, which is up 24% over the same period.Is New 90 Day High Low • Jan 05New 90-day high: US$10.31The company is up 6.0% from its price of US$9.75 on 06 October 2020. The American market is up 13% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Capital Markets industry, which is up 19% over the same period.Is New 90 Day High Low • Dec 14New 90-day high: US$9.98The company is up 1.0% from its price of US$9.85 on 14 September 2020. The American market is up 11% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Capital Markets industry, which is up 16% over the same period.공시 • Dec 10Hpx Corp. Announces Board ChangesOn December 3, 2020, F bio Mour o informed HPX Corp. of his decision to resign from the board of directors of the company and as a member of the audit committee and chairman of the nominating and corporate governance committee, effective as of December 3, 2020. Mr. Mour o's resignation was voluntary and to pursue other professional endeavors and not the result of any disagreement with the operations, policies or practices of the company. Marcos Vinicius Bernardes Peigo, a director of the Company, was appointed to the audit committee in order to fill the seat left vacant by Mr. Mour o's departure. In addition, Mr. Peigo was appointed as the new chairman of the nominating and corporate governance committee.주주 수익률HPXUS Capital MarketsUS 시장7D74.4%0.7%-4.1%1Y74.2%7.6%20.6%전체 주주 수익률 보기수익률 대 산업: HPX은 지난 1년 동안 7.6%의 수익을 기록한 US Capital Markets 산업보다 더 좋은 성과를 냈습니다.수익률 대 시장: HPX은 지난 1년 동안 20.6%를 기록한 US 시장보다 더 좋은 성과를 냈습니다.주가 변동성Is HPX's price volatile compared to industry and market?HPX volatilityHPX Average Weekly Movement54.7%Capital Markets Industry Average Movement3.6%Market Average Movement7.2%10% most volatile stocks in US Market16.6%10% least volatile stocks in US Market3.1%안정적인 주가: HPX의 주가는 지난 3개월 동안 US 시장보다 변동성이 컸습니다.시간에 따른 변동성: HPX의 주간 변동성은 지난 1년간 27%에서 55%로 증가했습니다.회사 소개설립직원 수CEO웹사이트2020n/aCarlos Leone Pianiwww.hpxcorp.com더 보기HPX Corp. 기초 지표 요약HPX의 순이익과 매출은 시가총액과 어떻게 비교됩니까?HPX 기초 통계시가총액US$146.31m순이익 (TTM)US$3.40m매출 (TTM)n/a43.1x주가수익비율(P/E)0.0x주가매출비율(P/S)HPX는 고평가되어 있습니까?공정 가치 및 평가 분석 보기순이익 및 매출최근 실적 보고서(TTM)의 주요 수익성 지표HPX 손익계산서 (TTM)매출US$0매출원가US$0총이익US$0기타 비용-US$3.40m순이익US$3.40m최근 보고된 실적Sep 30, 2022다음 실적 발표일해당 없음주당순이익(EPS)0.40총이익률0.00%순이익률0.00%부채/자본 비율-5.3%HPX의 장기 실적은 어땠습니까?과거 실적 및 비교 보기View Valuation기업 분석 및 재무 데이터 상태데이터최종 업데이트 (UTC 시간)기업 분석2023/03/07 19:56종가2023/03/06 00:00수익2022/09/30연간 수익2021/12/31데이터 소스당사의 기업 분석에 사용되는 데이터는 S&P Global Market Intelligence LLC에서 제공됩니다. 아래 데이터는 이 보고서를 생성하기 위해 분석 모델에서 사용됩니다. 데이터는 정규화되므로 소스가 제공된 후 지연이 발생할 수 있습니다.패키지데이터기간미국 소스 예시 *기업 재무제표10년손익계산서현금흐름표대차대조표SEC 양식 10-KSEC 양식 10-Q분석가 컨센서스 추정치+3년재무 예측분석가 목표주가분석가 리서치 보고서Blue Matrix시장 가격30년주가배당, 분할 및 기타 조치ICE 시장 데이터SEC 양식 S-1지분 구조10년주요 주주내부자 거래SEC 양식 4SEC 양식 13D경영진10년리더십 팀이사회SEC 양식 10-KSEC 양식 DEF 14A주요 개발10년회사 공시SEC 양식 8-K* 미국 증권에 대한 예시이며, 비(非)미국 증권에는 해당 국가의 규제 서식 및 자료원을 사용합니다.별도로 명시되지 않는 한 모든 재무 데이터는 연간 기간을 기준으로 하지만 분기별로 업데이트됩니다. 이를 TTM(최근 12개월) 또는 LTM(지난 12개월) 데이터라고 합니다. 자세히 알아보기.분석 모델 및 스노우플레이크이 보고서를 생성하는 데 사용된 분석 모델에 대한 자세한 내용은 당사의 Github 페이지에서 확인하실 수 있습니다. 또한 보고서 활용 방법에 대한 가이드와 YouTube 튜토리얼도 제공합니다.Simply Wall St 분석 모델을 설계하고 구축한 세계적 수준의 팀에 대해 알아보세요.산업 및 섹터 지표산업 및 섹터 지표는 Simply Wall St가 6시간마다 계산하며, 프로세스에 대한 자세한 내용은 Github에서 확인할 수 있습니다.분석가 소스HPX Corp.는 0명의 분석가가 다루고 있습니다. 이 중 명의 분석가가 우리 보고서에 입력 데이터로 사용되는 매출 또는 수익 추정치를 제출했습니다. 분석가의 제출 자료는 하루 종일 업데이트됩니다.
Valuation Update With 7 Day Price Move • Mar 02Investor sentiment improves as stock rises 170%After last week's 170% share price gain to US$27.07, the stock trades at a trailing P/E ratio of 67.6x. Average trailing P/E is 28x in the Capital Markets industry in the US. Total returns to shareholders of 173% over the past year.
Board Change • Feb 14High number of new and inexperienced directorsThere are 7 new directors who have joined the board in the last 3 years. The company's board is composed of: 7 new directors. No experienced directors. No highly experienced directors. CEO, CFO & Director Carlos Leone Piani is the most experienced director on the board, commencing their role in 2020. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of board continuity. Lack of experienced directors.
공시 • Nov 15HPX Corp. announced delayed 10-Q filingOn 11/14/2022, HPX Corp. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.
공시 • Jul 093GA Participações S.A. entered into a business combination agreement to acquire HPX Corp. (NYSE:HPX) from HPX Capital Partners LLC and others in a reverse merger transaction.3GA Participações S.A. entered into a business combination agreement to acquire HPX Corp. (NYSE:HPX) from HPX Capital Partners LLC and others in a reverse merger transaction on July 5, 2022. The combined company is expected to have a pro-forma enterprise value of approximately $581 million and a pro-forma implied market capitalization of approximately $798 million, assuming no redemptions from HPX Corp. shareholders. Upon closing of the Business Combination, Ambipar Emergency Response (“Ambipar Response”), a newly incorporated Cayman Islands exempted company that will hold the business of Emergência Participações S.A., is expected to become publicly listed on the NYSE under the ticker symbol “AMBI.” Ambipar Participações e Empreendimentos S.A. (“Ambipar Group”) (B3: AMBP3), currently the sole shareholder of Emergência Participações S.A., will remain a majority shareholder of Ambipar Response with an approximate 50% equity stake in Ambipar Response following the closing of the Business Combination and assuming no redemptions from HPX’s existing public shareholders, and up to 72% in case of total redemptions of HPX existing public shareholders. The economic ownership structure following the Business Combination is expected to be approximately: 50% Ambipar Group, 48% PIPE and HPX public shareholders, and 2% HPX sponsor. The consummation of the transactions contemplated by the Business Combination Agreement is subject to customary closing conditions, including approval by shareholders of HPX and Ambipar; HPX having at least $5,000,001 of net tangible assets; the receipt of approval for the New PubCo Class A Ordinary Shares to be listed on NYSE; delivery of the Contribution Agreement; HPX shall have at least $168,000,000 in cash and cash equivalents in the Trust Account; Parties will have received or have been deemed to have received all other necessary pre-Closing authorizations, consents, clearances, waivers and approvals of the Governmental Entities; The Registration Statement shall have become effective in accordance with the provisions of the Securities Act and other conditions. The Business Combination has been unanimously approved by the Board of Directors of Ambipar Group and HPX. Ambipar Participações e Empreendimentos S.A., shareholder of Emergência Participações S.A. also approved the merger agreement. Transaction is expected to close during the second half of 2022. Bank of America Merrill Lynch Banco Múltiplo S.A. is serving as financial advisor to Ambipar Response and Ambipar Group, and BofA Securities, Inc. is serving as the placement agent in connection with the PIPE offering. Mark Pflug and Grenfel Calheiros, Mark Brod, Tristan Brown, Lori Lesser, Mick Tuesley of Simpson Thacher & Bartlett LLP serving as U.S. legal advisors to Ambipar Response and Ambipar Group, and Mattos Filho, Veiga Filho, Marrey Jr e Quiroga Advogados is serving as Brazilian legal advisor to Ambipar Response and Ambipar Group. J. Mathias von Bernuth and Maxim Mayer-Cesiano of Skadden, Arps, Slate, Meagher & Flom LLP serving as U.S. legal advisors to HPX, Greenberg Traurig, LLP is serving as legal advisor on certain international diligence matters for HPX and BRZ Advogados as legal advisor on Brazilian matters. Shearman & Sterling LLP is acting as legal advisor to BofA Securities, Inc. in its capacity as the placement agent.
공시 • May 17HPX Corp. announced delayed 10-Q filingOn 05/16/2022, HPX Corp. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.
공시 • Apr 01HPX Corp. announced delayed annual 10-K filingOn 03/31/2022, HPX Corp. announced that they will be unable to file their next 10-K by the deadline required by the SEC.
Valuation Update With 7 Day Price Move • Mar 02Investor sentiment improves as stock rises 170%After last week's 170% share price gain to US$27.07, the stock trades at a trailing P/E ratio of 67.6x. Average trailing P/E is 28x in the Capital Markets industry in the US. Total returns to shareholders of 173% over the past year.
Board Change • Feb 14High number of new and inexperienced directorsThere are 7 new directors who have joined the board in the last 3 years. The company's board is composed of: 7 new directors. No experienced directors. No highly experienced directors. CEO, CFO & Director Carlos Leone Piani is the most experienced director on the board, commencing their role in 2020. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of board continuity. Lack of experienced directors.
공시 • Nov 15HPX Corp. announced delayed 10-Q filingOn 11/14/2022, HPX Corp. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.
공시 • Jul 093GA Participações S.A. entered into a business combination agreement to acquire HPX Corp. (NYSE:HPX) from HPX Capital Partners LLC and others in a reverse merger transaction.3GA Participações S.A. entered into a business combination agreement to acquire HPX Corp. (NYSE:HPX) from HPX Capital Partners LLC and others in a reverse merger transaction on July 5, 2022. The combined company is expected to have a pro-forma enterprise value of approximately $581 million and a pro-forma implied market capitalization of approximately $798 million, assuming no redemptions from HPX Corp. shareholders. Upon closing of the Business Combination, Ambipar Emergency Response (“Ambipar Response”), a newly incorporated Cayman Islands exempted company that will hold the business of Emergência Participações S.A., is expected to become publicly listed on the NYSE under the ticker symbol “AMBI.” Ambipar Participações e Empreendimentos S.A. (“Ambipar Group”) (B3: AMBP3), currently the sole shareholder of Emergência Participações S.A., will remain a majority shareholder of Ambipar Response with an approximate 50% equity stake in Ambipar Response following the closing of the Business Combination and assuming no redemptions from HPX’s existing public shareholders, and up to 72% in case of total redemptions of HPX existing public shareholders. The economic ownership structure following the Business Combination is expected to be approximately: 50% Ambipar Group, 48% PIPE and HPX public shareholders, and 2% HPX sponsor. The consummation of the transactions contemplated by the Business Combination Agreement is subject to customary closing conditions, including approval by shareholders of HPX and Ambipar; HPX having at least $5,000,001 of net tangible assets; the receipt of approval for the New PubCo Class A Ordinary Shares to be listed on NYSE; delivery of the Contribution Agreement; HPX shall have at least $168,000,000 in cash and cash equivalents in the Trust Account; Parties will have received or have been deemed to have received all other necessary pre-Closing authorizations, consents, clearances, waivers and approvals of the Governmental Entities; The Registration Statement shall have become effective in accordance with the provisions of the Securities Act and other conditions. The Business Combination has been unanimously approved by the Board of Directors of Ambipar Group and HPX. Ambipar Participações e Empreendimentos S.A., shareholder of Emergência Participações S.A. also approved the merger agreement. Transaction is expected to close during the second half of 2022. Bank of America Merrill Lynch Banco Múltiplo S.A. is serving as financial advisor to Ambipar Response and Ambipar Group, and BofA Securities, Inc. is serving as the placement agent in connection with the PIPE offering. Mark Pflug and Grenfel Calheiros, Mark Brod, Tristan Brown, Lori Lesser, Mick Tuesley of Simpson Thacher & Bartlett LLP serving as U.S. legal advisors to Ambipar Response and Ambipar Group, and Mattos Filho, Veiga Filho, Marrey Jr e Quiroga Advogados is serving as Brazilian legal advisor to Ambipar Response and Ambipar Group. J. Mathias von Bernuth and Maxim Mayer-Cesiano of Skadden, Arps, Slate, Meagher & Flom LLP serving as U.S. legal advisors to HPX, Greenberg Traurig, LLP is serving as legal advisor on certain international diligence matters for HPX and BRZ Advogados as legal advisor on Brazilian matters. Shearman & Sterling LLP is acting as legal advisor to BofA Securities, Inc. in its capacity as the placement agent.
공시 • May 17HPX Corp. announced delayed 10-Q filingOn 05/16/2022, HPX Corp. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.
공시 • Apr 01HPX Corp. announced delayed annual 10-K filingOn 03/31/2022, HPX Corp. announced that they will be unable to file their next 10-K by the deadline required by the SEC.
공시 • May 29HPX Corp. Receives Notice from the NYSE Regarding Delayed Filing of Quarterly ReportOn April 12, 2021, the Acting Director of the Division of Corporation Finance and Acting Chief Accountant of the U.S. Securities and Exchange Commission (the “SEC”) together issued a statement regarding the accounting and reporting considerations for warrants issued by special purpose acquisition companies entitled “Staff Statement on Accounting and Reporting Considerations for Warrants Issued by Special Purpose Acquisition Companies (‘SPACs’)” (the “SEC Staff Statement”). As previously disclosed, given the scope of the process for determining the appropriate accounting treatment of its outstanding warrants in accordance with the SEC Staff Statement and Accounting Standards Codification (“ASC”) 815-40, Derivatives and Hedging: Contracts in an Entities Own Equity, HPX Corp. (the “Company”) was unable to complete and file its Quarterly Report on Form 10-Q for the fiscal quarter ended March 31, 2021 (the “Form 10-Q”) by the required due date without unreasonable effort and expense. On May 25, 2021, HPX Corp. received a notice (the “Notice”) from the New York Stock Exchange (the “Exchange”) indicating that, as a result of not having timely filed the Form 10-Q with the SEC, the Company is not in compliance with Section 802.01E of the NYSE Listed Company Manual (the “Listing Rule”). The Listing Rule requires listed companies to timely file all required periodic reports with the SEC. The Notice indicated that the Company can regain compliance with the Exchange’s listing standards at any time prior to November 24, 2021 by filing the Form 10-Q. If the Company fails to file the Form 10-Q by such date, the Exchange may grant, at its sole discretion, an extension for the Company to regain compliance, depending on the specific circumstances. The Notice also stated that the Exchange may nevertheless commence delisting proceedings at any time if it deems that the circumstances warrant. While the Company can provide no assurances as to timing, the Company plans to file the Form 10-Q as soon as practicably possible, and no later than November 24, 2021, and regaining compliance with the Listing Rule.
공시 • May 19HPX Corp. announced delayed 10-Q filingOn 05/18/2021, HPX Corp. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.
Is New 90 Day High Low • Jan 26New 90-day high: US$10.61The company is up 10.0% from its price of US$9.65 on 27 October 2020. The American market is up 17% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Capital Markets industry, which is up 24% over the same period.
Is New 90 Day High Low • Jan 05New 90-day high: US$10.31The company is up 6.0% from its price of US$9.75 on 06 October 2020. The American market is up 13% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Capital Markets industry, which is up 19% over the same period.
Is New 90 Day High Low • Dec 14New 90-day high: US$9.98The company is up 1.0% from its price of US$9.85 on 14 September 2020. The American market is up 11% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Capital Markets industry, which is up 16% over the same period.
공시 • Dec 10Hpx Corp. Announces Board ChangesOn December 3, 2020, F bio Mour o informed HPX Corp. of his decision to resign from the board of directors of the company and as a member of the audit committee and chairman of the nominating and corporate governance committee, effective as of December 3, 2020. Mr. Mour o's resignation was voluntary and to pursue other professional endeavors and not the result of any disagreement with the operations, policies or practices of the company. Marcos Vinicius Bernardes Peigo, a director of the Company, was appointed to the audit committee in order to fill the seat left vacant by Mr. Mour o's departure. In addition, Mr. Peigo was appointed as the new chairman of the nominating and corporate governance committee.
